Paul Greengard, Nobel Prize-Winning Neuroscientist, Dies at 93

Paul Greengard, Nobel Prize-Winning Neuroscientist, Dies at 93


Paul Greengard, an American neuroscientist whose 15-year quest to understand how brain cells communicate provided new insights into psychological diseases and earned him a Nobel Prize, and who used his entire $400,000 award to create an academic prize in memory of the mother he never knew, died on Saturday in Manhattan. He was 93.

His death was confirmed by Rockefeller University, where he had worked since 1983.

Dr. Greengard received the 2000 Nobel Prize in Physiology or Medicine with Dr. Arvid Carlsson of Sweden and Dr. Eric R. Kandel of the United States for independent discoveries related to the ways brain cells relay messages about movement, memory and mental states. Their discoveries offered new insights into disorders linked to errors in cell communication, such as Parkinson’s disease, schizophrenia, bipolar disorder and drug addiction.

Dr. Greengard’s research described how cells react to dopamine, an important chemical messenger in the brain. His work provided the underlying science for many antipsychotic drugs, which modulate the strength of chemical signals in the brain.

“Our work shows the details of how dopamine produces these effects — in other words, what’s wrong in these diseases and what can be done to correct them,” Dr. Greengard said.

Dr. Greengard’s research extended from the late 1960s to the mid-1980s. For much of the period, his work was ignored. A majority of biologists believed brain cells communicated through the use of electrical signals. To them, the only thing that mattered was whether a cell fired off a signal.

“There was a point when I thought they would not be accepted in my lifetime,” Dr. Greengard said in a 2011 interview, referring to the results of his many experiments.

Ultimately, Dr. Greengard showed that electrical and chemical signaling worked in tandem. He discovered that chemical groups called phosphates within cells trigger a cascade of chemical changes that amplify the dopamine signal. This response, in turn, makes it possible for cells to fire electrical signals. Today the field he pioneered, called signal transduction, is an important area of study.

Paul Greengard was born on Dec. 11, 1925, in Brooklyn. His father was a vaudeville performer who became a perfume salesman; his mother, a homemaker, died giving birth to him. When Dr. Greengard was 13 months old, his father, who was Jewish, married an Episcopalian who raised Dr. Greengard and his two sisters in the Christian tradition. He did not know about his mother until he was in college; he needed information about his family background to fill out a form.

Dr. Greengard received his doctorate in 1953 from Johns Hopkins University, one of the few institutions that offered a degree in biophysics at the time. After five years of postdoctoral work and a stint in the pharmaceutical industry, he joined the Yale University faculty in 1968. He moved to Rockefeller University in 1983 and spent the rest of his career there.

Toward the end of his life, his research turned to understanding the cell signaling defects in specific disorders, including Alzheimer’s disease, Parkinson’s disease, schizophrenia and depression.

Dr. Greengard was married three times and divorced twice. Survivors include his wife, the sculptor Ursula von Rydingsvard; three children, Claude Greengard, Leslie Greengard and Ursula Anne von Rydingsvard; a sister, Linda Greengard; and six grandchildren.

Before Dr. Greengard went to Yale, he spent a several months at Vanderbilt University working with Dr. Earl Sutherland Jr., an eminent biochemist. Dr. Sutherland had made important discoveries about the chemical signaling that takes place in fat and muscle cells in response to messages from hormones; he went on to receive the 1971 Nobel Prize in Physiology or Medicine for this work.

Dr. Sutherland’s research roused Dr. Greengard’s curiosity. Did the sort of chemical signaling observed in fat and muscle cells also take place in brain cells?

“No one was terribly interested — it wasn’t ready for prime time,” Dr. Greengard said, recalling reactions to his ideas in a 2000 interview with The New York Times. “People said, ‘Poor Paul, I’m sure he’ll find his way back onto the right path.’”



Source …

Share this page...
CBDPet CBD Hemp Oil Extract Dietary Supplement

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.